UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-25 | Future report Set alerts | |
| Q2 2022 | 2022-07-27 | 4.55 | 4.55 |
| Q1 2022 | 2022-04-27 | 4.90 | 4.90 |
| Q4 2021 | 2022-02-09 | 2.88 | 2.88 |
| Q3 2021 | 2021-10-27 | 2.83 | 2.83 |
| Q2 2021 | 2021-07-28 | 3.40 | 3.40 |
| Q1 2021 | 2021-04-28 | 4.44 | 4.44 |
| Q4 2020 | 2021-02-10 | -0.51 | -0.51 |
| Q3 2020 | 2020-10-28 | 3.36 | 3.36 |
| Q2 2020 | 2020-07-30 | 4.79 | 4.79 |
| 2016-06-28 | Reiterated Rating | Credit Suisse | Hold | |
| 2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Hold | |
| 2016-06-15 | Reiterated Rating | Leerink Swann | Outperform | $75.00 |
| 2016-05-04 | Downgrade | Goldman Sachs | Neutral to Sell | $75.00 to $45.00 |
| 2016-05-04 | Downgrade | Goldman Sachs Group Inc. | Neutral to Sell | $75.00 to $45.00 |
| 2016-05-02 | Boost Price Target | Leerink Swann | Outperform | $75.00 to $105.00 |
| 2016-04-30 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-30 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-04-29 | Lower Price Target | Stifel Nicolaus | Buy | $83.00 to $64.00 |
| 2016-04-29 | Downgrade | Bank of America | Neutral to Underperform | |
| 2016-04-29 | Reiterated Rating | Wedbush | Outperform | $68.00 to $82.00 |
| 2016-04-29 | Downgrade | Bank of America Corp. | Neutral to Underperform | |
| 2016-04-12 | Reiterated Rating | Wedbush | Outperform | $82.00 |
| 2016-03-28 | Boost Price Target | Credit Suisse | Neutral | $42.00 to $58.00 |
| 2016-02-23 | Reiterated Rating | Cantor Fitzgerald | Hold | $65.00 |
| 2016-02-09 | Reiterated Rating | Cantor Fitzgerald | Hold | $60.00 |
| 2016-01-08 | Reiterated Rating | Jefferies Group | Buy | $84.00 to $73.00 |
| 2016-01-06 | Lower Price Target | Barclays | Equal Weight | $76.00 to $72.00 |
| 2016-01-06 | Lower Price Target | Barclays PLC | Equal Weight | $76.00 to $72.00 |
| 2015-12-16 | Initiated Coverage | Credit Suisse | Neutral | $64.00 |
| 2015-11-26 | Lower Price Target | S&P Equity Research | Hold | $32.00 to $30.00 |
| 2015-11-02 | Boost Price Target | Barclays | Equal Weight | $72.00 to $76.00 |
| 2015-11-02 | Boost Price Target | Leerink Swann | Outperform | $97.00 to $105.00 |
| 2015-09-18 | Boost Price Target | Susquehanna | Positive | $85.00 to $92.00 |
| 2015-09-18 | Reiterated Rating | Leerink Swann | Buy | $95.00 to $97.00 |
| 2015-09-16 | Initiated Coverage | JPMorgan Chase & Co. | Neutral | $84.00 |
| 2015-09-10 | Boost Price Target | Wedbush | $80.00 to $98.00 | |
| 2015-09-03 | Reiterated Rating | Leerink Swann | Buy | $95.00 |
| 2015-09-03 | Reiterated Rating | Cantor Fitzgerald | Hold | $60.00 to $65.00 |
| 2015-08-03 | Boost Price Target | Leerink Swann | Outperform | $90.00 to $95.00 |
| 2015-07-31 | Upgrade | Stifel Nicolaus | Hold to Buy | $88.00 |
| 2015-07-15 | Reiterated Rating | Jefferies Group | Buy | $80.00 to $84.00 |
| 2015-06-15 | Reiterated Rating | Jefferies Group | Buy | $80.00 |
| 2015-06-02 | Boost Price Target | Deutsche Bank | Hold | $62.00 to $67.00 |
| 2015-06-02 | Boost Price Target | Deutsche Bank AG | Hold | $62.00 to $67.00 |
| 2015-05-23 | Reiterated Rating | Leerink Swann | Outperform | $70.00 to $80.00 |
| 2015-05-08 | Boost Price Target | Jefferies Group | Buy | $79.00 to $80.00 |
| 2015-05-08 | Boost Price Target | Barclays | Equal Weight | $70.00 to $72.00 |
| 2015-03-20 | Boost Price Target | Barclays | Equal Weight | $66.00 to $70.00 |
| 2015-02-13 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $55.00 to $58.00 |
| 2015-02-13 | Reiterated Rating | Jefferies Group | Buy | $58.00 to $70.00 |
| 2015-02-13 | Boost Price Target | Deutsche Bank | Hold | $52.00 to $55.00 |
| 2015-02-13 | Boost Price Target | Barclays | Equal Weight | $56.00 to $66.00 |
| 2015-01-08 | Boost Price Target | Barclays | Equal Weight | $45.00 to $56.00 |
| 2015-01-06 | Reiterated Rating | Deutsche Bank | Hold | $42.00 to $52.00 |
| 2014-11-18 | Reiterated Rating | Bank of America | Buy | $52.00 to $57.00 |
| 2014-11-03 | Reiterated Rating | Jefferies Group | Buy | $50.00 to $58.00 |
| 2014-11-03 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $46.00 to $55.00 |
| 2014-10-31 | Reiterated Rating | Barclays | Equal Weight | $46.00 to $45.00 |
| 2014-10-31 | Upgrade | Leerink Swann | Market Perform to Outperform | |
| 2014-09-19 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $40.00 to $46.00 |
| 2014-08-06 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $35.00 to $40.00 |
| 2014-08-01 | Reiterated Rating | Cantor Fitzgerald | Hold | $35.00 to $40.00 |
| 2014-08-01 | Reiterated Rating | Jefferies Group | Buy | $54.00 to $50.00 |
| 2014-07-31 | Reiterated Rating | Barclays | Equal Weight | $44.00 to $46.00 |
| 2014-07-31 | Reiterated Rating | Deutsche Bank | Hold | $43.00 to $42.00 |
| 2014-07-14 | Boost Price Target | Susquehanna | $52.00 to $53.00 | |
| 2014-07-10 | Reiterated Rating | Jefferies Group | Buy | $47.00 to $54.00 |
| 2014-06-30 | Boost Price Target | Leerink Swann | $40.00 to $45.00 | |
| 2014-06-27 | Initiated Coverage | Sterne Agee CRT | Buy | $69.00 |
| 2014-05-15 | Boost Price Target | Cantor Fitzgerald | $35.00 to $40.00 | |
| 2014-05-02 | Boost Price Target | Monness Crespi & Hardt | Buy | $47.00 to $51.00 |
| 2014-05-02 | Boost Price Target | Deutsche Bank | Hold | $36.00 to $40.00 |
| 2014-05-02 | Reiterated Rating | Bank of America | Buy | $42.00 to $44.00 |
| 2014-01-23 | Initiated Coverage | Credit Suisse | Neutral | $42.00 |
| 2014-01-13 | Initiated Coverage | Wood & Company | Buy | |
| 2013-11-21 | Initiated Coverage | Morgan Stanley | Equal Weight | |
| 2013-11-18 | Initiated Coverage | Leerink Swann | Market Perform | $35.00 |
| 2013-11-01 | Lower Price Target | Credit Suisse | Neutral | $42.00 to $37.00 |
| 2013-10-31 | Lower Price Target | Deutsche Bank | Hold | $40.00 to $36.00 |
| 2013-10-31 | Reiterated Rating | JPMorgan Chase & Co. | Hold | $39.00 |
| 2013-10-31 | Lower Price Target | Barclays | Equal Weight | $46.00 to $42.00 |
| 2013-09-22 | Boost Price Target | JPMorgan Chase & Co. | Neutral | $29.00 to $39.00 |
| 2013-09-16 | Upgrade | Jefferies Group | Hold to Buy | $36.00 to $47.00 |
| 2013-02-12 | Reiterated | Cantor Fitzgerald | Hold | $28 to $32 |
| 2012-06-07 | Reiterated | Cantor Fitzgerald | Hold | $36 to $31 |
| 2012-06-07 | Reiterated | Barclays | Equal Weight | $31 to $21 |
| 2012-04-09 | Downgrade | Cantor Fitzgerald | Buy to Hold | |
| 2012-01-30 | Reiterated | UBS | Neutral | $22 to $31 |
| 2012-01-05 | Reiterated | Barclays Capital | Equal Weight | $23 to $26 |
| 2011-09-20 | Reiterated | UBS | Neutral | $21 to $18 |
| 2016-06-28 | Reiterated Rating | Credit Suisse | Hold | |
| 2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Hold | |
| 2016-06-15 | Reiterated Rating | Leerink Swann | Outperform | $75.00 |
| 2016-05-04 | Downgrade | Goldman Sachs | Neutral to Sell | $75.00 to $45.00 |
| 2016-05-04 | Downgrade | Goldman Sachs Group Inc. | Neutral to Sell | $75.00 to $45.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MOH 404 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 6.58M |
| Capital World Investors | 5.51M |
| BlackRock Inc. | 4.29M |
| FMR LLC | 3.02M |
| BlackRock Fund Advisors | 2.69M |
| STATE STREET CORP | 2.45M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.15M |
| WELLINGTON MANAGEMENT CO LLP | 1.71M |
| RENAISSANCE TECHNOLOGIES LLC | 1.46M |
| BlackRock Institutional Trust Company, N.A. | 1.32M |
| Capital International Investors | 1.23M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.14M |
| Invesco Ltd. | 1.02M |
| GOLDMAN SACHS GROUP INC | 0.97M |
| VICTORY CAPITAL MANAGEMENT INC | 0.84M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MOLINA JOHN C CFO | 0.80% (372930) | MOH / |
| WHITE JOSEPH W CPA VP, Accounting | 0.17% (78742) | MOH / |
| MOLINA J MARIO MD President & CEO | 0.13% (61125) | MOH / |
| Barlow Jeff D. SVP-General Counsel | 0.12% (55922) | MOH / |
| Zubretsky Joseph M President & CEO | 0.12% (55648) | AET / MOH / THG / |
| Nichols Norman Pres, MMS | 0.11% (51590) | MOH / |
| Wilson Keith Chief Medical Officer | 0.06% (29441) | MOH / |
| BAYER TERRY Chief Operating Officer | 0.06% (28730) | CWT / MOH / |
| ORLANDO STEVEN J | 0.05% (25531) | MOH / |
| Rubino Lisa A Senior Vice President | 0.05% (25084) | MOH / |
| ROMNEY RONNA | 0.05% (22851) | MOH / PKOH / |
| FEDAK CHARLES Z | 0.05% (21326) | MOH / |
| SZABO JOHN P JR | 0.04% (17097) | MOH / |
| Murray Frank E MD | 0.04% (16811) | MOH / |
| WOLF DALE B | 0.04% (16281) | MOH / |
| James Steven | 0.03% (15024) | MOH / |
| Schapiro Richard M | 0.02% (11382) | MOH / |
| Carruthers Garrey | 0.02% (8411) | MOH / |
| COOPERMAN DANIEL | 0.02% (7257) | MOH / |
UM